<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04442477</url>
  </required_header>
  <id_info>
    <org_study_id>6027-2</org_study_id>
    <nct_id>NCT04442477</nct_id>
  </id_info>
  <brief_title>Neurodevelopment at 5.5 Years of Age in Children Who Received Infant Formula With Enriched Protein Fractions</brief_title>
  <official_title>Neurodevelopment at 5.5 Years of Age in Children Who Received Infant Formula With Enriched Protein Fractions</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Mead Johnson Nutrition</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Mead Johnson Nutrition</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      This is a follow-up study of a multi-center, double-blind, randomized, controlled,
      parallel-designed, prospective trial and is intended to evaluate neurodevelopment at 5.5
      years of age and health outcomes through 5.5 years of age in participants who received one of
      two staged study formulas through one year of age.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">June 15, 2020</start_date>
  <completion_date type="Anticipated">June 30, 2021</completion_date>
  <primary_completion_date type="Anticipated">June 30, 2021</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Wechsler Preschool &amp; Primary Scale of Intelligence™ (Fourth Edition; WPPSI™-IV)</measure>
    <time_frame>At 5.5 years of age</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Dimensional Change Card Sort (DCCS)</measure>
    <time_frame>At 5.5 years of age</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Stroop Task</measure>
    <time_frame>At 5.5 years of age</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Functional Near Infrared Spectroscopy (fNIRS)</measure>
    <time_frame>At 5.5 years of age</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Child Behavior Checklist (CBCL)</measure>
    <time_frame>At 5.5 years of age</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Body weight</measure>
    <time_frame>At 5.5 years of age</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Body height</measure>
    <time_frame>At 5.5 year of age</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Health history outcomes</measure>
    <time_frame>At 5.5 years of age</time_frame>
  </secondary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Anticipated">116</enrollment>
  <condition>Cognitive Ability, General</condition>
  <arm_group>
    <arm_group_label>Experimental: Enriched Protein Fractions</arm_group_label>
    <description>This group was given Infant formula with enriched protein fractions</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Active Comparator: Protein Fractions</arm_group_label>
    <description>This group was given Infant formula with protein fractions</description>
  </arm_group>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Enriched Protein Fractions</intervention_name>
    <description>Enriched protein fractions</description>
    <arm_group_label>Experimental: Enriched Protein Fractions</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Protein Fraction</intervention_name>
    <description>Protein fractions</description>
    <arm_group_label>Active Comparator: Protein Fractions</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Participants who previously consumed study formula through one year of age in MJN Project
        6027.
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Participant who previously consumed study formula through one year of age in MJN
             Project 6027

          -  5.5 years of age (i.e. when child turns 5 years and 6 months old ± 2 months) at Visit
             1

          -  Signed informed consent obtained for child's participation in the study

        Exclusion Criteria:

          -  No exclusion criteria
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>64 Months</minimum_age>
    <maximum_age>68 Months</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Fei Li</last_name>
    <role>Principal Investigator</role>
    <affiliation>Shanghai Children's Medical Center</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Steven Wu, M.D.</last_name>
    <role>Study Director</role>
    <affiliation>Mead Johnson/RB</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Ashlee Kirchoff</last_name>
    <phone>812-479-7997</phone>
    <email>ashlee.kirchoff@rb.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>Fuyang Fifth People's Hospital</name>
      <address>
        <city>Anhui</city>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Weirong Hu</last_name>
    </contact>
  </location>
  <location_countries>
    <country>China</country>
  </location_countries>
  <verification_date>June 2020</verification_date>
  <study_first_submitted>June 18, 2020</study_first_submitted>
  <study_first_submitted_qc>June 18, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">June 22, 2020</study_first_posted>
  <last_update_submitted>June 18, 2020</last_update_submitted>
  <last_update_submitted_qc>June 18, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">June 22, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

